A new class of weight loss and diabetes drugs could reduce inflammation in the liver, kidneys, heart and even the brain, Nature reported Jan. 26.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Weight loss drugs show strides in reducing inflammation
